Your browser doesn't support javascript.
loading
A diagnostic phase III/IV seamless design to investigate the diagnostic accuracy and clinical effectiveness using the example of HEDOS and HEDOS II.
Pepic, Amra; Stark, Maria; Friede, Tim; Kopp-Schneider, Annette; Calderazzo, Silvia; Reichert, Maria; Wolf, Michael; Wirth, Ulrich; Schopf, Stefan; Zapf, Antonia.
Afiliación
  • Pepic A; Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.
  • Stark M; Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.
  • Friede T; Department of Medical Statistics, University Medical Center Göttingen, Göttingen, Germany.
  • Kopp-Schneider A; Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Calderazzo S; Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Reichert M; CRI-The Clinical Research Institute, Munich, Germany.
  • Wolf M; CRI-The Clinical Research Institute, Munich, Germany.
  • Wirth U; Clinic for General, Visceral and Transplant Surgery, Hospital of the Ludwig-Maximilians-University, Munich, Germany.
  • Schopf S; RoMed Klinik Bad Aibling, Academic University Hospital of the Technical University of Munich, Bad Aibling, Germany.
  • Zapf A; Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.
Stat Methods Med Res ; 33(3): 433-448, 2024 Mar.
Article en En | MEDLINE | ID: mdl-38327081
ABSTRACT
The development process of medical devices can be streamlined by combining different study phases. Here, for a diagnostic medical device, we present the combination of confirmation of diagnostic accuracy (phase III) and evaluation of clinical effectiveness regarding patient-relevant endpoints (phase IV) using a seamless design. This approach is used in the Thyroid HEmorrhage DetectOr Study (HEDOS & HEDOS II) investigating a post-operative hemorrhage detector named ISAR-M THYRO® in patients after thyroid surgery. Data from the phase III trial are reused as external controls in the control group of the phase IV trial. An unblinded interim analysis is planned between the two study stages which includes a recalculation of the sample size for the phase IV part after completion of the first stage of the seamless design. The study concept presented here is the first seamless design proposed in the field of diagnostic studies. Hence, the aim of this work is to emphasize the statistical methodology as well as feasibility of the proposed design in relation to the planning and implementation of the seamless design. Seamless designs can accelerate the overall trial duration and increase its efficiency in terms of sample size and recruitment. However, careful planning addressing numerous methodological and procedural challenges is necessary for successful implementation as well as agreement with regulatory bodies.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proyectos de Investigación / Hemorragia Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Stat Methods Med Res Año: 2024 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proyectos de Investigación / Hemorragia Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Stat Methods Med Res Año: 2024 Tipo del documento: Article País de afiliación: Alemania
...